Pharmalive - The Pulse of the Pharmaceutical Industry
Search Criteria: Search In:  
Conferences


R&D Directions Insider

Dual-filing feat a rarity for little guy

Wednesday, February 17th, 2010

You may have read recently about a small biotech outfit in New Jersey having successfully submitted simultaneous regulatory filings in the United States and Europe for Luveniq, a new oral treatment for non-infectious uveitis, an inflammatory condition of the eye that can lead to blindness (see the release here). You ...

Posted in Uncategorized, clinical trials, filed for approval | No Comments »

Closer peek at Novartis-Alcon potential

Wednesday, January 6th, 2010

Not surprisingly, moods are turning a tad testy in Novartis’ bid to gain full control of Swiss neighbor Alcon Inc. (see reports here and here). But talk of “coercive’’ tactics, minority shareholder protection, and independent director committees aside, just how visionary the potential eye-care deal really is appears a bit ...

Posted in Uncategorized | No Comments »

   
about us | advertise | contact us | home
terms of use | privacy | copyright | site map 		©2012 UBM Canon